Judith L. Rapoport's Legacy in Child Psychiatry and Neuroscience
Judith L. Rapoport, a pioneering figure in child psychiatry, passed away in 2026. Her career was marked by significant contributions to understanding and treating ADHD, OCD, and childhood-onset schizophrenia. Rapoport's work at the National Institute of Mental Health (NIMH) led to the FDA approval of clomipramine for treating OCD in children and adolescents. Her research also demonstrated that the human brain continues to grow throughout adolescence, with many neuropsychiatric disorders linked to abnormal growth trajectories. Rapoport's influence extended through her mentorship, with many of her mentees now leading academic programs worldwide. 
